-
Anal Cancer Treatment Market to Surpass US$ 1,242.9 Million by 2028, Says Coherent Market Insights (CMI)
20 Oct 2021 13:30 GMT
… II clinical trials results for … antibody, INCMGA0012 for treatment of anal cancer … ISA Pharmaceuticals, Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co., … Drug Type:
Fluorouracil
Cisplatin
Carboplatin
Others (Others include Mitomycin, Oxaliplatin …
-
Global Platinum based Cancer Drug Market 2021 Research by Top Manufacturers, Segmentation, Industry Growth, Regional Analysis and Forecast by 2027
18 Oct 2021 21:03 GMT
… the global Platinum based Cancer Drug market. This report identifies various … :
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr … market is segmented as:
Cisplatin
Oxaliplatin
Carboplatin
Others
Based on application …
-
Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
18 Oct 2021 00:25 GMT
… registrational or pivotal clinical trials.
In China, sintilimab … with oxaliplatin and capecitabine for the first-line treatment of … #39;s National Reimbursement Drug List (NRDL) in … high-quality innovative medicines for the treatment of cancer, autoimmune …
-
Metastatic Colorectal Cancer Pipeline Review | Clinical Trials Analysis Report 2021 | DelveInsight
07 Oct 2021 00:00 GMT
… Review | Clinical Trials Analysis Report 2021 … Pharmaceutical Co., Ltd., Suzhou Zelgen Biopharmaceuticals Co., Ltd, Henlix Biotech … with fluoropyrimidine-, oxaliplatin-, and irinotecan-based … drug is in Phase I clinical trial evaluation for the treatment …
-
Can a new drug make pancreatic cells responsive to chemotherapy?
04 Oct 2021 00:42 GMT
… , resistant to every anti-cancer treatment. Targeting TAK-1 could be … alliance with the anti-cancer drugs gemcitabine, oxaliplatin and SN-38 which … the bedside, conducting a clinical trial that could demonstrate the safety …
-
FDA Expands Lilly's ERBITUX (cetuximab) Label with Combination of BRAFTOVI (encorafenib) for the Treatment of BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC) after Prior Therapy
29 Sep 2021 00:35 GMT
… .S. Food and Drug Administration (FDA) has granted approval … patients who have failed oxaliplatin- and irinotecan-based … Monitor patients weekly during treatment for hypomagnesemia, hypocalcemia, … , as with any pharmaceutical product, there are substantial …
-
Platinum based Cancer Drug Market: Global Industry Status by Manufacturing Size, Share, Top key Players, Business Strategy, Future Trends and Growth Rate till 2026
23 Sep 2021 06:28 GMT
… information regarding Platinum based Cancer Drug market size, evaluation of … amp;nbsp; Qilu Pharmaceutical
… amp;nbsp; Hengrui Medicine
… nbsp; Oxaliplatin
…
-
Platinum based Cancer Drug Market Technology Advancement and Future Prospect 2021-2027| Debiopharm, Pfizer, ASK Pharma, Teva, Yi Bai Pharmaceutical, Dr Reddy’s Laboratories
18 Sep 2021 00:18 GMT
… compounds, particularly in the treatment of ovarian cancer, bladder … Novartis, Sun Pharma, Hengrui Medicine, Sanofi, Qilu Pharmaceutical. This report provides an … based Cancer Drug Market Segmentation: Segment By Type Cisplatin, Oxaliplatin, Carboplatin, …
-
Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021
18 Sep 2021 00:10 GMT
… based on platinum drugs for unresectable locally advanced … registrational or pivotal clinical trials.
In China, sintilimab … with oxaliplatin and capecitabine for the first-line treatment … high quality innovative medicines for the treatment of cancer, …
-
Zanidatamab Phase 2 Clinical Trial Demonstrates Promising Response Rate and Durability in First-Line HER2-Positive Gastroesophageal Adenocarcinoma (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress
16 Sep 2021 11:04 GMT
… either CAPOX (capecitabine/oxaliplatin; n=14), FP (5FU … pivotal clinical trials globally as a targeted treatment option for … Drug designations from the European Medicines Agency for the treatments … FDA and is currently enrolling in a pivotal clinical trial …
About
© 1995-2021